Seed targeting with tiny anti-miR-155 inhibits malignant progression of multiple myeloma cells
Author:
Publisher
Informa UK Limited
Subject
Pharmaceutical Science
Link
http://www.tandfonline.com/doi/pdf/10.1080/10256018808623883
Reference44 articles.
1. Multiple myeloma
2. Deregulated microRNAs in multiple myeloma
3. Multiple Myeloma
4. In Vitro and in Vivo Anti-tumor Activity of miR-221/222 Inhibitors in Multiple Myeloma
5. Genetics and molecular profiling of multiple myeloma: Novel tools for clinical management?
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Reactive oxygen species/glutathione dual sensitive nanoparticles with encapsulation of miR155 and curcumin for synergized cancer immunotherapy;Journal of Nanobiotechnology;2024-07-08
2. Erianin as a Promising Novel Agent in the Treatment of Neuroblastoma: The Anticancer Effects and Underlying Molecular Mechanisms;Anti-Cancer Agents in Medicinal Chemistry;2023-06
3. Targeting miRNAs and Other Non-Coding RNAs as a Therapeutic Approach: An Update;Non-Coding RNA;2023-04-13
4. Mechanism of exosomal miR-155 derived from bone marrow mesenchymal stem cells on stemness maintenance and drug resistance in myeloma cells;Journal of Orthopaedic Surgery and Research;2021-10-24
5. Pedagogical conditions for teaching future medical workers for the diagnosis and treatment of multiple myeloma;Management of Education;2021-05-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3